| 1 |
DDC
| [9] Tyrosine metabolism Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism | D00558
D00558
|
Carbidopa
| [9] 2 2, 4, 6, 13, 17, 90, 140, 164, 201 |
| 2 |
DRD1
| [10] Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Amphetamine addiction, Morphine addiction, Alcoholism | D00059
D00059
|
Levodopa
| [8] 2 2, 4, 6, 17, 90, 140, 164, 201 |
| 3 |
DRD2
| [8] Rap1 signaling pathway Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson disease, Cocaine addiction, Alcoholism | D00059
D00059
|
Levodopa
| [8] 2 2, 4, 6, 17, 90, 140, 164, 201 |
| 4 |
DRD3
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Dopaminergic synapse | D00059
D00059
|
Levodopa
| [8] 2 2, 4, 6, 17, 90, 140, 164, 201 |
| 5 |
DRD4
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Dopaminergic synapse | D00059
D00059
|
Levodopa
| [8] 2 2, 4, 6, 17, 90, 140, 164, 201 |
| 6 |
DRD5
| [4] Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Dopaminergic synapse | D00059
D00059
|
Levodopa
| [8] 2 2, 4, 6, 17, 90, 140, 164, 201 |
| 7 |
GABRA1
| [6] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | D04282
D04282
|
Gaboxadol
| [2] 201 201, 206 |
| 8 |
GABRA2
| [6] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | D04282
D04282
|
Gaboxadol
| [2] 201 201, 206 |
| 9 |
GABRA3
| [6] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | D04282
D04282
|
Gaboxadol
| [2] 201 201, 206 |
| 10 |
GABRA4
| [6] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | D04282
D04282
|
Gaboxadol
| [2] 201 201, 206 |
| 11 |
GABRA5
| [6] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | D04282
D04282
|
Gaboxadol
| [2] 201 201, 206 |
| 12 |
GABRA6
| [6] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | D04282
D04282
|
Gaboxadol
| [2] 201 201, 206 |
| 13 |
GABRB1
| [6] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | D04282
D04282
|
Gaboxadol
| [2] 201 201, 206 |
| 14 |
GABRB2
| [6] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | D04282
D04282
|
Gaboxadol
| [2] 201 201, 206 |
| 15 |
GABRB3
| [6] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | D04282
D04282
|
Gaboxadol
| [2] 201 201, 206 |
| 16 |
GABRD
| [5] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | D04282
D04282
|
Gaboxadol
| [2] 201 201, 206 |
| 17 |
GABRE
| [5] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | D04282
D04282
|
Gaboxadol
| [2] 201 201, 206 |
| 18 |
GABRG1
| [5] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | D04282
D04282
|
Gaboxadol
| [2] 201 201, 206 |
| 19 |
GABRG2
| [5] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | D04282
D04282
|
Gaboxadol
| [2] 201 201, 206 |
| 20 |
GABRG3
| [5] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | D04282
D04282
|
Gaboxadol
| [2] 201 201, 206 |
| 21 |
GABRP
| [5] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | D04282
D04282
|
Gaboxadol
| [2] 201 201, 206 |
| 22 |
GABRQ
| [5] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | D04282
D04282
|
Gaboxadol
| [2] 201 201, 206 |